0.34Open0.05Pre Close1 Volume19 Open Interest86.00Strike Price34.00Turnover222.67%IV9.39%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.34Extrinsic Value100Contract SizeAmericanOptions Type0.1243Delta0.0360Gamma232.15Leverage Ratio-1.5082Theta0.0001Rho28.86Eff Leverage0.0052Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet